These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 415139

  • 1. Reduced Fc-receptor bearing cells in peripheral bloods of patients with systemic lupus erythematosus and in rheumatoid synovial fluids.
    Nakai H, Morito T, Tanimoto K, Horiuchi Y.
    J Rheumatol; 1977; 4(4):405-13. PubMed ID: 415139
    [Abstract] [Full Text] [Related]

  • 2. [Clinical application of Fc-rosette. III. Reduction of Fc receptor bearing cells in the peripheral blood of SLE and rheumatoid synovial fluids (author's transl)].
    Nakai H, Morito T, Tanimoto K, Horiuchi Y.
    Ryumachi; 1977 Jul; 17(4):373-80. PubMed ID: 905902
    [No Abstract] [Full Text] [Related]

  • 3. Immunological characteristics of lymphocytes in synovial fluid and peripheral blood in patients with rheumatoid arthritis.
    Michałkiewicz J.
    Arch Immunol Ther Exp (Warsz); 1978 Jul; 26(1-6):801-5. PubMed ID: 312088
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Fc-rosette formation by synovial fluids from patients with rheumatoid arthritis.
    Hashimoto Y, Morito T, Tanimoto K, Horiuchi Y.
    Ann Rheum Dis; 1977 Apr; 36(2):170-5. PubMed ID: 857743
    [Abstract] [Full Text] [Related]

  • 5. Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.
    Winchester RJ, Winfield JB, Siegal F, Wernet P, Bentwich Z, Kunkel HG.
    J Clin Invest; 1974 Nov; 54(5):1082-92. PubMed ID: 4138924
    [Abstract] [Full Text] [Related]

  • 6. Characterization of antibody-dependent cell-mediated cytotoxicity in rheumatoid synovial fluid.
    Abrahamsen TG.
    Scand J Rheumatol; 1981 Nov; 10(1):55-61. PubMed ID: 7221496
    [Abstract] [Full Text] [Related]

  • 7. [Study of T and B lymphocytes in blood and synovial fluid during rheumatoid arthritis].
    Sany J, Clot J, Rosenberg F, Serre H.
    Rev Rhum Mal Osteoartic; 1977 May; 44(5):317-22. PubMed ID: 329397
    [Abstract] [Full Text] [Related]

  • 8. Markers of activated T cells on synovial fluid lymphocytes in rheumatoid arthritis.
    Mathieu A.
    Boll Ist Sieroter Milan; 1979 Jan 31; 57(6):774-8. PubMed ID: 317895
    [Abstract] [Full Text] [Related]

  • 9. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
    Moutsopoulos H, Fye KH, Sawada S, Becker MJ, Goldstein A, Talal N.
    Clin Exp Immunol; 1976 Dec 31; 26(3):563-73. PubMed ID: 795579
    [Abstract] [Full Text] [Related]

  • 10. Fc-rosette inhibition by hypocomplementaemic systemic lupus erythematosus sera.
    Morito T, Tanimoto K, Hashimoto Y, Horiuchi Y, Juji T.
    Ann Rheum Dis; 1975 Oct 31; 35(5):415-21. PubMed ID: 1086653
    [Abstract] [Full Text] [Related]

  • 11. Predominance of T-lymphocytes with a high-affinity receptor for sheep red blood cells in the synovial fluid of patients with rheumatoid arthritis. A short communication.
    Gramatzki M, Kalden JR.
    Z Rheumatol; 1981 Oct 31; 40(1):21-4. PubMed ID: 6971545
    [Abstract] [Full Text] [Related]

  • 12. In vitro studies on lymphocytotoxicity to synovial cells and Chang cells in rheumatoid arthritis patients and healthy controls.
    Warnatz H, Thommes M.
    Z Rheumatol; 1979 Oct 31; 38(3-4):129-37. PubMed ID: 312567
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F, Siddiqui AA.
    Clin Chim Acta; 2006 Aug 31; 370(1-2):100-7. PubMed ID: 16513103
    [Abstract] [Full Text] [Related]

  • 14. [Inhibition of expontaneous cytotoxicity and antibody dependency by rheumatoid synovial fluid].
    Noguera Hernando E, Kreisler M, Durantez A, Larrea Gayarre A, de Landazuri MO, Cruz Martínez J.
    Allergol Immunopathol (Madr); 1978 Aug 31; 6(3):253-62. PubMed ID: 717203
    [Abstract] [Full Text] [Related]

  • 15. Autologous rosette formation in systemic lupus erythematosus.
    Bodolay E, Szegedi G.
    Acta Med Hung; 1983 Aug 31; 40(2-3):81-9. PubMed ID: 6608094
    [Abstract] [Full Text] [Related]

  • 16. Increased EA-rosette formation by lymphocytes from patients with rheumatoid arthritis.
    Sharpin RK, Wilson JD.
    Clin Exp Immunol; 1977 Aug 31; 29(2):205-12. PubMed ID: 908172
    [Abstract] [Full Text] [Related]

  • 17. Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor-ligand binding and internalization.
    Salmon JE, Kimberly RP, Gibofsky A, Fotino M.
    J Immunol; 1984 Nov 31; 133(5):2525-31. PubMed ID: 6481162
    [Abstract] [Full Text] [Related]

  • 18. [Lymphocytic subpopulations implicated in the rheumatoid rosette phenomenon].
    Sany J, Clot J, Sip HM, Charmasson E, Serre H.
    Rev Rhum Mal Osteoartic; 1975 May 31; 42(5):309-16. PubMed ID: 806958
    [Abstract] [Full Text] [Related]

  • 19. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
    Elson CJ, Carter SD, Cottrell BJ, Scott DG, Bacon PA, Wallington TB.
    Clin Exp Immunol; 1985 Feb 31; 59(2):285-92. PubMed ID: 3978872
    [Abstract] [Full Text] [Related]

  • 20. The effect of sera from patients with connective tissue diseases on red cell binding and phagocytosis by monocytes.
    Temple A, Loewi G.
    Immunology; 1977 Jul 31; 33(1):109-14. PubMed ID: 873570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.